Autovaccination revisited: potential to boost antiviral immunity and facilitate HIV-1 cure/remission in children.
Parker HR. et al, (2025), Curr Opin HIV AIDS
Long-term non-progression in children living with HIV: estimates from international cohort data.
Jackson C. et al, (2025), AIDS
Biomarkers of vaccine safety and efficacy in vulnerable populations: Lessons from the fourth international precision vaccines conference
Amodio D. et al, (2025), Vaccine, 43
Early inflammation as a footprint of increased mortality risk in infants living with HIV from three African countries.
Morrocchi E. et al, (2024), Sci Rep, 14
Analytical treatment interruption in children living with HIV: position statement from the EPIICAL consortium.
Kuhn L. et al, (2024), Lancet HIV
Sustained aviraemia despite anti-retroviral therapy non-adherence in male children following in utero hiv transmission.
Bengu N. et al, (2024), Nat Med
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity.
Liu C. et al, (2024), Cell Rep Med
Prevalence of resistance-associated viral variants to the HIV-specific broadly neutralising antibody 10-1074 in a UK bNAb-naïve population.
Zacharopoulou P. et al, (2024), Front Immunol, 15
Impact of early antiretroviral therapy, early life immunity and immune sex differences on HIV disease and posttreatment control in children.
Herbert NG. and Goulder PJR., (2023), Curr Opin HIV AIDS, 18, 229 - 236
Hepatitis B Virus Prevalence and Mother-to-Child Transmission Risk in an HIV Early Intervention Cohort in KwaZulu-Natal, South Africa.
Millar J. et al, (2023), Open Forum Infect Dis, 10
Effective early antiretroviral therapy in perinatal-HIV infection reduces subsequent plasma inflammatory profile.
Nguyen AN. et al, (2023), Pediatr Res
Evaluation of QuantiFERON SARS-CoV-2 interferon-γ release assay following SARS-CoV-2 infection and vaccination.
Johnson SA. et al, (2023), Clin Exp Immunol, 212, 249 - 261
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75.
Huo J. et al, (2023), Cell Rep, 42
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus.
Fidler S. et al, (2023), Clin Infect Dis, 76, 201 - 209
Paediatric HIV slow-progression is associated with early CD8+ T-cell PD-1 expression and a stem-like phenotype.
Adriano Vieira V. et al, (2023), JCI Insight
Age- and sex-specific differences in immune responses to BNT162b2 COVID-19 and live-attenuated influenza vaccines in UK adolescents.
Jay C. et al, (2023), Front Immunol, 14
Cellular immunity to SARS-CoV-2 following intrafamilial exposure in seronegative family members.
Jay C. et al, (2023), Front Immunol, 14
Exposed seronegative: Cellular immune responses to SARS-CoV-2 in the absence of seroconversion.
Jay C. et al, (2023), Front Immunol, 14